CSL Vifor

Genexine's anemia drug matches Roche-CSL product in phase 3, laying groundwork for Asia filings
Fierce Biotech
Tue, 04/11/23 - 10:07 am
Genexine
chronic kidney disease
anemia
Roche
CSL Vifor
Mircera